SYSTEMATIC REVIEW article
Front. Med.
Sec. Dermatology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1641322
The Efficacy of Topical Treatments for Acanthosis Nigricans: A Systematic Review of Randomized Controlled Trials
Provisionally accepted- 1College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia
- 2Division of Dermatology, Department of Medicine, Ministry of the National Guard-Health Affairs, Jeddah, Saudi Arabia., jeddah, Saudi Arabia
- 3Emergency medicine, East Jeddah General Hospital, Jeddah, Saudi Arabia, jeddah, Saudi Arabia
- 4Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia, riyadh, Saudi Arabia
- 5Family Medicine, Ministry of Health, Jeddah, Saudi Arabia, jeddah, Saudi Arabia
- 6Employee Health Clinic, King Abdulaziz Medical City, Jeddah, Saudi Arabia, jeddah, Saudi Arabia
- 7Intensive care unit, King Salman bin Abdulaziz medical city, Medinah, SA, medina, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Acanthosis nigricans (AN) is a skin disorder marked by darkening and thickening of the skin, often linked to metabolic abnormalities. This systematic review of randomized controlled trials (RCTs) assesses the comparative effectiveness and tolerability of different topical treatment options of AN, aiming to determine the most suitable therapeutic strategies. Methods: A comprehensive literature search was conducted across PubMed, Scopus, ClinicalTrials.gov, Web of Science, and the Cochrane Library, yielding 6,407 studies. After screening and a full-text review, seven randomized controlled trials (n=268) assessed topical urea (10–20%), tretinoin (0.025– 0.05%), salicylic acid (10%), and chemical peels such as glycolic acid (35– 70%) and trichloroacetic acid (15%) over 8 weeks to 2 months, primarily on the neck and axilla. Outcomes included melanin and erythema indices (M/E), ANASI/ANSC scores, Investigator's and Participant's Global Evaluation (IGE/PGE), and adverse events. Results: Urea demonstrated significant efficacy in reducing erythema, particularly at higher concentrations (20%), with mild adverse events such as stinging or irritation. Tretinoin was the most effective for reducing dark pigmentation, especially on the neck, and patients were more satisfied with it than with glycolic acid. Salicylic acid (10%) gave results similar to urea, with only mild side effects like dryness or peeling. Trichloroacetic acid (15%) peel was more effective than glycolic acid (35%) peel, both in skin improvement and patient satisfaction after 8 weeks. Overall, side effects with all treatments were mild and went away on their own. Conclusion: Both urea and tretinoin are effective treatments for AN, choice of therapy should be individualized tretinoin for predominant hyperpigmentation, urea for erythema or lower irritation tolerance, salicylic acid as a tolerable alternative, and TCA peel when stronger procedural options are suitable glycolic peel showed more modest effects.
Keywords: Acanthosis Nigricans, Urea, Tretinoin, Hyperkeratosis, Hyperpigmentation, Erythema, Keratolytic Agents, glycolic acid
Received: 04 Jun 2025; Accepted: 15 Sep 2025.
Copyright: © 2025 Alamri, Alraddadi, Alzahrani, Abualola, Maaddawi, Alharthy, Alkhashan, Ashqan, Shaheen, Almahdi and Althobaiti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Awadh Mohammed Alamri, alamriw@hotmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.